Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Tumor necrosis factor-alpha-mediated severity of idiopathic retinal periphlebitis in young adults (Eales' disease): implication for anti-TNF-alpha therapy.

Authors: Saxena, S  Pant, AB  Khanna, VK  Singh, K  Shukla, RK  Meyer, CH  Singh, VK 
Citation: Saxena S, etal., J Ocul Biol Dis Infor. 2010 Jul 16;3(1):35-8. doi: 10.1007/s12177-010-9053-3.
Pubmed: (View Article at PubMed) PMID:21139707
DOI: Full-text: DOI:10.1007/s12177-010-9053-3

Tumor necrosis factor-alpha (TNF-alpha) is a pleiotropic inflammatory cytokine. Tumor necrosis factor-alpha was evaluated in the serum samples of patients with idiopathic retinal periphlebitis in young adults (Eales' disease). Retinal periphlebitis was graded according to a new grading system based on severity of inflammation (grade 1-4). Quantification of the TNF-alpha levels was carried out using ELISA kit in the serum samples of young adults with idiopathic retinal periphlebitis (n = 17) and healthy controls (n = 17) of similar age. Tumor necrosis factor-alpha level was found to be significantly raised in cases with retinal periphlebitis as compared with controls (p < 0.001). Higher levels of TNF-alpha were found to be associated with increased severity of retinal periphlebitis. Tumor necrosis factor-alpha represents a novel target for controlling inflammatory activity in idiopathic retinal periphlebitis. Higher levels of TNF-alpha, in association with the increased severity of retinal periphlebitis, have implications for early anti-TNF-alpha therapy.

Annotation

Disease Annotations
Objects Annotated

Additional Information

 
CRRD Object Information
CRRD ID: 7387277
Created: 2013-10-28
Species: All species
Last Modified: 2013-10-28
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.